Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Iron(iii) Pyrophosphate, Soluble
2. Bcp30644
3. Ferric Pyrophosphate, Soluble [nf]
4. Pyrophosphoric Acid, Iron Salt, Soluble
5. H 61
6. Sodium Ferricitropyrophosphate;iron(iii) Pyrophosphate, Soluble
7. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Iron(3+) Sodium Salt (1:1:1), Mixt. With Iron(3+) Diphosphate
Molecular Weight | 497.72 g/mol |
---|---|
Molecular Formula | C6H5Fe2NaO14P2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 3 |
Exact Mass | 497.775094 g/mol |
Monoisotopic Mass | 497.775094 g/mol |
Topological Polar Surface Area | 276 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 364 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Ferric Pyrophosphate Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferric Pyrophosphate Citrate, including repackagers and relabelers. The FDA regulates Ferric Pyrophosphate Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferric Pyrophosphate Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ferric Pyrophosphate Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ferric Pyrophosphate Citrate supplier is an individual or a company that provides Ferric Pyrophosphate Citrate active pharmaceutical ingredient (API) or Ferric Pyrophosphate Citrate finished formulations upon request. The Ferric Pyrophosphate Citrate suppliers may include Ferric Pyrophosphate Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Ferric Pyrophosphate Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ferric Pyrophosphate Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ferric Pyrophosphate Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ferric Pyrophosphate Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ferric Pyrophosphate Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ferric Pyrophosphate Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ferric Pyrophosphate Citrate suppliers with NDC on PharmaCompass.
Ferric Pyrophosphate Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ferric Pyrophosphate Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferric Pyrophosphate Citrate GMP manufacturer or Ferric Pyrophosphate Citrate GMP API supplier for your needs.
A Ferric Pyrophosphate Citrate CoA (Certificate of Analysis) is a formal document that attests to Ferric Pyrophosphate Citrate's compliance with Ferric Pyrophosphate Citrate specifications and serves as a tool for batch-level quality control.
Ferric Pyrophosphate Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Ferric Pyrophosphate Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ferric Pyrophosphate Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferric Pyrophosphate Citrate EP), Ferric Pyrophosphate Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferric Pyrophosphate Citrate USP).
LOOKING FOR A SUPPLIER?